Nestle lifts sales guidance as it faces ‘sharp increase’ in costs
The Swiss company said it expects organic sales growth between 8% and 8.5% for the year.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Food and drink giant Nestle has been hit by a “sharp increase” in costs but lifted its sales guidance for the year.
The KitKat and Cheerios maker updated investors about its latest trading ahead of an investor seminar on Tuesday.
The Swiss company said it expects organic sales growth between 8% and 8.5% for the year, improving upon previous guidance of around 8%.
It said organic sales growth, which does not include acquisitions or currency changes, was 8.5% over the nine months to September.
Earlier this year, the group hiked prices by more than 5% and warned that customers could face further increases due to inflation.
On Tuesday, the company said it is set to increase profit margins despite the “impact of a sharp increase in cost inflation in 2021 and 2022”.
We have made significant progress in recent years, accelerating organic growth, increasing margins and enhancing capital efficiency
Nestle also confirmed that it is considering a sale for peanut allergy treatment business Palforzia, only two years after buying the division.
It is exploring strategic options for the arm following “slower than expected adoption” by patients.
Mark Schneider, Nestle chief executive officer, said: “We have made significant progress in recent years, accelerating organic growth, increasing margins and enhancing capital efficiency.
“Today, we outline our value creation model and targets for 2025 as we aim to deliver consistently in turbulent times.
“We will continue to invest for future growth, investing behind our brands, delivering impactful innovation, leveraging digitalisation and improving speed and agility.
“Creating shared value for stakeholders remains our focus, with Good for You, Good for the Planet at the heart of our strategy.”